Sebastian Arrizabalaga | Medicine and Health Sciences | Innovative Research Award

Published on by Top Teachers

Innovative Research Award

Sebastian Arrizabalaga — Oregon Health & Science University, United States

Sebastian Arrizabalaga
Affiliation Oregon Health & Science University
Country United States
Scopus ID 58650782300
Documents 3
Citations 128
h-index 2
Subject Area Ophthalmology
Event Top Teachers Awards
ORCID 0009-0007-5387-3007

Sebastian Arrizabalaga is a researcher affiliated with Oregon Health & Science University whose work encompasses experimental ophthalmology, retinal disease research, neural stem cell formulations, preclinical models, and quantitative assessment of retinal neuroprotection. His research experience combines laboratory experimentation, animal-based studies, imaging, data analysis, and research project management, supporting translational investigations relevant to retinal disorders and emerging therapeutic strategies. [1][2]

Abstract

Sebastian Arrizabalaga’s academic profile is centered on ophthalmic and retinal research conducted at Oregon Health & Science University. His research activities include evaluating neural stem cell approaches, studying retinal neuroprotection in animal models, and contributing to preclinical investigations involving retinal therapeutics. His technical background includes spectroscopy, chromatography, fluorescence imaging, confocal microscopy, fundus imaging, electroretinography, ocular procedures, and quantitative data analysis. Published work demonstrates participation in studies addressing retinal degeneration, geographic atrophy, and experimental therapeutic development. [1][3][4][5]

Keywords

Ophthalmology; retinal research; neural stem cells; retinal neuroprotection; geographic atrophy; age-related macular degeneration; preclinical research; retinal imaging; electroretinography; animal models; translational medicine; cell-based therapy.

Introduction

Sebastian Arrizabalaga’s research trajectory connects biochemical laboratory training with experimental ophthalmology. After completing a Bachelor of Arts in Chemistry at Reed College, including a thesis examining the functionality of the bacterial tellurium resistance protein TerB, he developed broader expertise in laboratory science, animal experimentation, imaging, and retinal research. His subsequent work at Oregon Health & Science University has focused on experimental approaches relevant to retinal degeneration and therapeutic development. [2][4]

Research Profile

His current research profile includes project and experiment management, preparation of clinical trial approval documentation, laboratory administration, animal colony management, experimental design, and quantitative analysis. Technical competencies encompass UV/Vis spectroscopy, biochemistry, liquid chromatography–mass spectrometry, fluorescence spectroscopy, R programming, immunofluorescence staining, confocal microscopy, optokinetic tracking, fundus imaging, electroretinography, ocular injections and implants, cryosectioning, and microtome-based tissue preparation.[1][2]

  • Retinal and ophthalmic experimental research.
  • Neural stem cell and retinal neuroprotection studies.
  • Preclinical investigation of therapies for retinal degeneration.
  • Quantitative retinal imaging and functional assessment.
  • Laboratory, animal-model, and research-project management.

Research Contributions

A principal contribution of Arrizabalaga’s research record is the quantitative evaluation of retinal neuroprotection produced by distinct human neural stem cell formulations in the Royal College of Surgeons rat model. This work provides experimental evidence for comparing cell-based approaches within a retinal degeneration model and contributes to the broader development of regenerative strategies for retinal disease.[4]

His research also includes work on improving human neural stem cell formulations for potential application to geographic atrophy, a form of advanced dry age-related macular degeneration. In related preclinical research, his collaborative publication record intersects with investigations of retinal gene editing and cell-based therapeutic safety and efficacy, reflecting a translational research pathway from experimental formulation and biological evaluation toward potential clinical applications. [3][5]

Publications

Sebastian Arrizabalaga’s highly relevant publications include a 2023 study quantifying retinal neuroprotection from two human neural stem cell formulations in the RCS rat, followed by a 2024 study addressing improvements to human neural stem cell formulations for geographic atrophy treatment. His collaborative research record also includes work on retinal genome editing using lipid nanoparticles and preclinical studies of GMP-grade retinal pigment epithelial cells for dry age-related macular degeneration, placing his contributions within active translational ophthalmology research. [4][3][5]

  1. Gautam, M., Jozic, A., Su, G. L. N., et al. (2023). Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nature Communications, 14, 6468.
  2. Arrizabalaga, S., Uchida, N., Curtis, A., Navarro, I., Stoddard, J., Tsukamoto, A., Leng, T., & Ryals, R. C. (2023). Quantification of retinal neuroprotection achieved by two different human neural stem cell formulations in the RCS rat. Investigative Ophthalmology & Visual Science, 64(8), 3841.
  3. Arrizabalaga, S., Uchida, N., Curtis, A. G., Stoddard, J., Sheffield, A., Tsukamoto, A., Leng, T., & Ryals, R. C. (2024). Improving human neural stem cell formulations for geographic atrophy treatment. Investigative Ophthalmology & Visual Science, 65(7), 1535.
  4. Surendran, H., Soundararajan, L., Patlolla, N., Stoddard, J., Arrizabalaga, S., Liu, Z., Gopal, L., Su, X., Ryals, R. C., Battu, R., & Pal, R. (2024). IND-enabling preclinical safety and efficacy studies using GMP-grade human iPSC-derived retinal pigment epithelial cells for treating dry age-related macular degeneration. Investigative Ophthalmology & Visual Science, 65(7), 716.

Research Impact

The research record is relevant to contemporary ophthalmology because retinal degeneration and geographic atrophy require improved methods for protecting or replacing vulnerable retinal cells. Sebastian Arrizabalaga’s participation in studies involving neural stem cell formulations, retinal imaging, functional testing, and preclinical safety and efficacy contributes to the experimental evidence base used to evaluate candidate regenerative and translational therapies. The listed academic profile reports 128 citations across three documents, with an h-index of 2.[1]

Award Suitability

For the Innovative Research Award associated with the Top Teachers Awards, Sebastian Arrizabalaga presents a research profile characterized by laboratory-based ophthalmic investigation, multidisciplinary collaboration, quantitative experimentation, and translational relevance. His work on retinal neuroprotection and neural stem cell formulations provides a coherent research theme connecting experimental models with potential therapeutic development. The combination of technical laboratory expertise, animal-model research, imaging, and publication activity supports consideration within an innovation-focused academic recognition framework.[1][2]

Conclusion

Sebastian Arrizabalaga’s academic record reflects developing expertise in experimental ophthalmology, retinal degeneration research, neural stem cell approaches, and preclinical therapeutic evaluation. His publications and research responsibilities demonstrate engagement with collaborative translational studies addressing retinal neuroprotection and geographic atrophy. Together with a broad technical laboratory skill set and experience managing experimental research activities, these elements form a focused profile in contemporary retinal science. [1]

References

  1. Scopus author profile for Sebastian Arrizabalaga, author identifier 58650782300. https://www.scopus.com/pages/authors/58650782300
  2. ORCID record for Sebastian Arrizabalaga, ORCID 0009-0007-5387-3007. https://orcid.org/0009-0007-5387-3007
  3. Gautam, M., Jozic, A., Su, G. L. N., et al. (2023). Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nature Communications, 14, 6468. https://doi.org/10.1038/s41467-023-42189-3
  4. Arrizabalaga, S., Uchida, N., Curtis, A., Navarro, I., Stoddard, J., Tsukamoto, A., Leng, T., & Ryals, R. C. (2023). Quantification of retinal neuroprotection achieved by two different human neural stem cell formulations in the RCS rat. Investigative Ophthalmology & Visual Science, 64(8), 3841. https://iovs.arvojournals.org/article.aspx?articleid=2788186
  5. Arrizabalaga, S., Uchida, N., Curtis, A. G., Stoddard, J., Sheffield, A., Tsukamoto, A., Leng, T., & Ryals, R. C. (2024). Improving human neural stem cell formulations for geographic atrophy treatment. Investigative Ophthalmology & Visual Science, 65(7), 1535. https://iovs.arvojournals.org/article.aspx?articleid=2796734